EGFR and lung adenocarcinoma: Our data adds confirmation with earlier work that lung squamous cell carcinoma shows a rare presence of two ubiquitous mutations seen in lung adenocarcinomas, KRAS and EGFR, are rare in lung squamous cell carcinoma (Ding et al., 2008).